Quantum Biopharma (QNTM) Net Equity Issued and Repurchased (2020 - 2026)

Quantum Biopharma (QNTM) reported Net Equity Issued and Repurchased of $5.4 million for Q1 2026, down 23.41% sequentially from $7.0 million in Q3 2024.

Quantum Biopharma (QNTM) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Quantum Biopharma (QNTM) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $5.4 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 141.90 Mn
10 Quantum Biopharma 13.00 Bn 13.00 Bn - 5.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.40 Mn
Mar 31, 2026 5.40 Mn
Sep 30, 2024 7.05 Mn
Sep 30, 2024 7.05 Mn
Jun 30, 2024 1.84 Mn
Jun 30, 2024 1.84 Mn
Mar 31, 2024 296,437.00
Mar 31, 2024 296,437.00
Mar 31, 2021 38.34 Mn
Mar 31, 2021 38.34 Mn
Sep 30, 2020 9.55 Mn
Sep 30, 2020 9.55 Mn